Guillain–Barré syndrome (GBS) has several clinical variants. The sensory presentations of
GBS are atypical but well-recognized. We report a patient who presented with predominantly …

The coronavirus disease-2019 (COVID-19) pandemic originated in Wuhan (China) on
December 2019. So far, more than 1,500,000 cases have been confirmed worldwide (> …

Guillain-Barré syndrome (GBS) in an immune mediated disease that affects peripheral
nerves with possible life-threatening complications. GBS has multiple subtypes including …

Abstract Guillain-Barré Syndrome (GBS) is an immune-mediated polyneuropathy, most often
occurring within weeks of an infection. Cases of COVID-19–related GBS have been …

Abstract Objective: Guillain-Barré syndrome (GBS) is an acute immune-mediated
polyradiculoneuropathy that is often related to a previous infectious exposure. GBS emerged …

Discussion GBS is a heterogenous group of acute immune-mediated generalized
polyradiculoneuropathies commonly precipitated by an infectious illness. GBS has been …

Discussion COVID-19 presents with several neurological manifestations, however
peripheral neuropathy is less reported between various presentations of COVID-19 [3]. In a …

Guillain-Barre syndrome(GBS) is a rare autoimmune-mediated polyradiculoneuropathy that
is often preceded by a viral infection. GBS has emerged as a complication of coronavirus …

Objectives Guillain-Barré syndrome (GBS) is an acute immune-mediated
polyradiculoneuropathy that is often related to a previous infectious exposure. GBS emerged …

Novel outbreaks with COVID-19 can cause multiple systemic manifestations, including
autoimmune disease. Among all the infections, respiratory complications are the most …